| 000 | 01508 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513032450.0 | ||
| 264 | 0 | _c19951121 | |
| 008 | 199511s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, J T | |
| 245 | 0 | 0 |
_aPeptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cOct 1995 |
||
| 300 |
_a285-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a3T3 Cells _xmetabolism |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBombesin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEsophagus _xmetabolism |
| 650 | 0 | 4 | _aGastrin-Releasing Peptide |
| 650 | 0 | 4 |
_aGlioma _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNeurokinin B _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPancreas _xmetabolism |
| 650 | 0 | 4 |
_aPeptides _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Bombesin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSubstance P _xanalogs & derivatives |
| 700 | 1 | _aCoy, D H | |
| 700 | 1 | _aMantey, S A | |
| 700 | 1 | _aJensen, R T | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 275 _gno. 1 _gp. 285-95 |
|
| 999 |
_c7562018 _d7562018 |
||